Stay updated on Cabozantinib for PN in NF1: Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for PN in NF1: Clinical Trial page.

Latest updates to the Cabozantinib for PN in NF1: Clinical Trial page
- Check3 days agoChange DetectedNo substantive content changes. The page now shows Revision: v3.0.2 and removes the 'Back to Top' element, indicating a minor UI update.SummaryDifference0.1%
- Check10 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.1%
- Check17 days agoChange DetectedThe web page has updated its facility name and location details, specifically adding new locations in Washington D.C. and St. Louis, while removing previous references to Neurofibromatosis Type 1. Additionally, the version has been updated from v2.16.12 to v3.0.0.SummaryDifference1%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.0%
- Check39 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.0%
- Check46 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.6%
Stay in the know with updates to Cabozantinib for PN in NF1: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for PN in NF1: Clinical Trial page.